Pharmetheus, a leading company in biosimulation and biotech, is pleased to announce the appointment of two esteemed professionals to its Board of Directors, further enhancing the company’s strategic vision and expertise. These appointments, effective immediately, represent an important step forward in Pharmetheus’s commitment to innovation, growth, and excellence.
With an increasing need to optimize and de-risk the drug development process, expertise in regulatory affairs is of the essence. Pharmetheus is growing its capabilities within the field to support clients in increasing the probability of a successful drug development program.
Read our story about Dr. Andrea Henrich, who joined Pharmetheus to develop her skills and work with experts in the industry. From the start she felt the company’s passion for knowledge sharing and it has helped her both in her role as a modeler and team member.
Ulcerative colitis is an inflammatory bowel disease, affecting the rectum and the colon, impacting the quality of life of the afflicted. It is estimated that there are around 5 million cases worldwide (Le Berre et al., The Lancet, issue 10401, 2023).
When the current demand for pharmacometricians outmatches the supply, it is urgent to establish the skills demanded to excel in the field and collectively advance it. Our colleague, Elodie Plan, shares her view in this publication, alongside several leading experts in academia, industry, contract research organizations, clinical medicine, and regulatory.
The authors of the publication discuss several angles, such as three areas of expertise necessary for a pharmacometrician to possess: technical competence, contextual knowledge, and soft skills, and how life-long learning will be key as the field evolves.
“This therapy has significantly transformed the treatment of aggressive hematological malignancies.” explains Anna Mc Laughlin, “However, despite its success, up to 60% of patients do not respond long-term. Alternative approaches beyond dose titration are required to increase exposure”